• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by OrthoPediatrics Corp.

    5/15/25 12:50:40 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care
    Get the next $KIDS alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 8)


    OrthoPediatrics Corp.

    (Name of Issuer)


    Class A common stock, $0.00025 par value

    (Title of Class of Securities)


    68752L100

    (CUSIP Number)


    12/31/2024

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    68752L100


    1Names of Reporting Persons

    Brown Capital Management, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    MARYLAND
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,002,044.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,882,405.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,882,405.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    7.77 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    OrthoPediatrics Corp.
    (b)Address of issuer's principal executive offices:

    2850 Frontier Drive, Warsaw, Indiana 46582
    Item 2. 
    (a)Name of person filing:

    Brown Capital Management, LLC
    (b)Address or principal business office or, if none, residence:

    1201 N. Calvert Street, Baltimore, Maryland 21202
    (c)Citizenship:

    State of Maryland
    (d)Title of class of securities:

    Class A common stock, $0.00025 par value
    (e)CUSIP No.:

    68752L100
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    1882405
    (b)Percent of class:

    7.77%
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    1002044

     (ii) Shared power to vote or to direct the vote:

    None

     (iii) Sole power to dispose or to direct the disposition of:

    1882405

     (iv) Shared power to dispose or to direct the disposition of:

    None

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    All of the shares set forth in Item 4 are owned by various investment advisory clients of Brown Capital Management, LLC, which is deemed to be a beneficial owner of those shares pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, due to its discretionary power to make investment decisions over such shares and/or its ability to vote such shares.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Brown Capital Management, LLC
     
    Signature:/s/ Eddie C. Brown
    Name/Title:Eddie C. Brown, CEO
    Date:05/15/2025

    Comments accompanying signature:  After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    Get the next $KIDS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KIDS

    DatePrice TargetRatingAnalyst
    4/7/2025$37.00Buy
    Lake Street
    1/25/2024$39.00 → $31.00Buy → Hold
    Truist
    3/3/2022$83.00 → $65.00Buy
    Needham
    12/22/2021$75.00 → $68.00Buy
    BTIG
    12/21/2021$78.00 → $75.00Buy
    Truist Securities
    8/6/2021$70.00 → $77.00Market Outperform
    JMP Securities
    More analyst ratings

    $KIDS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO and CFO Hite Fred bought $98,525 worth of shares (5,076 units at $19.41), increasing direct ownership by 2% to 213,065 units (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    8/25/25 10:24:55 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    Director Hughes Bryan W was granted 8,401 shares, increasing direct ownership by 65% to 21,227 units (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    5/28/25 9:02:07 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    Director Infante (Reynolds) Marie C was granted 8,401 shares, increasing direct ownership by 74% to 19,766 units (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    5/28/25 9:00:19 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO and CFO Hite Fred bought $98,525 worth of shares (5,076 units at $19.41), increasing direct ownership by 2% to 213,065 units (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    8/25/25 10:24:55 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System

    WARSAW, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the first U.S. surgical procedures with the VerteGlide Spinal Growth Guidance System ("VerteGlide"), used to treat Early Onset Scoliosis ("EOS"). Dr. Richard McCarthy, a pediatric orthopedic spine surgeon in Louisville, Kentucky who, along with Dr. Kent Walker, performed one of the first procedures shared, "The first procedures with VerteGlide were a great success. For these patients, there is a very limited set of options, and this breakthrough growth

    9/10/25 7:00:00 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.

    WARSAW, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics announced today a new distribution partnership with MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries. This collaboration will expand access to MY01's Continuous Perfusion Sensing Technology™ (CPST™) Platform for children and adolescents, a population at great risk for acute compartment syndrome. Acute compartment syndrome is a time-sensitive emergency that disproportionately affects children with a floating elbow1, tibial2 and forearm3 fractures, and other ort

    9/5/25 7:00:00 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors

    WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025. "We're excited to welcome Kelly Fischer to the OrthoPediatrics Board of Directors. Her proven expertise in financial leadership at Cook Medical will be a significant asset as we execute our strategy and expand our

    8/25/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    SEC Filings

    View All

    OrthoPediatrics Corp. filed SEC Form 8-K: Leadership Update

    8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)

    8/11/25 3:34:38 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by OrthoPediatrics Corp.

    10-Q - ORTHOPEDIATRICS CORP (0001425450) (Filer)

    8/6/25 3:25:16 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)

    8/5/25 4:33:16 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on OrthoPediatrics with a new price target

    Lake Street initiated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $37.00

    4/7/25 8:25:17 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics downgraded by Truist with a new price target

    Truist downgraded OrthoPediatrics from Buy to Hold and set a new price target of $31.00 from $39.00 previously

    1/25/24 7:05:43 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    Needham reiterated coverage on OrthoPediatrics with a new price target

    Needham reiterated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $65.00 from $83.00 previously

    3/3/22 11:28:34 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Leadership Updates

    Live Leadership Updates

    View All

    OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors

    WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025. "We're excited to welcome Kelly Fischer to the OrthoPediatrics Board of Directors. Her proven expertise in financial leadership at Cook Medical will be a significant asset as we execute our strategy and expand our

    8/25/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation

    WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company's cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.​ The Crossroads Pediatric Device Consortium is a multi-institutional initiative focused on accelerating the development, approval, and availability of medical devices designed specifically for pediatric patients. Founding member

    3/17/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Joins Alliance for Pediatric Device Innovation

    WARSAW, Ind., Oct. 12, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, has announced a strategic partnership with Children's National Hospital in Washington, DC under the "Alliance for Pediatric Device Innovation" (APDI), to advice the development and commercialization of medical devices designed for children. Along with Children's National, APDI consortium members include Johns Hopkins University, CIMIT at Mass General Brigham, Tufts Medical Center and Medstar Health Research Institute. The Company will serve as APDI's strategic advisor and role model for devic

    10/12/23 8:05:00 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Financials

    Live finance-specific insights

    View All

    OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance

    WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 and Business Highlights       Helped over 37,000 children in the second quarter of 2025Generated new record high total revenue of $61.1 million for the second quarter of 2025, up 16% from $52.8 million in second quarter 2024; domestic revenue increased 17% and international revenue increased 12% in the quarterGrew worldwide Trauma & Deformity revenue 10% and worldwide Scoliosis revenue 35%

    8/5/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025

    WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2025 financial results on August 5, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 5, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for

    7/22/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance

    WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 and Business Highlights Helped a record of nearly 39,000 children in the first quarter of 2025Generated total revenue of $52.4 million for the first quarter of 2025, up 17% from $44.7 million in first quarter 2024; domestic revenue increased 19% and international revenue increased 11% in the quarterGrew worldwide Trauma & Deformity revenue 14% and worldwide Scoliosis revenue 34% in the first

    5/7/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by OrthoPediatrics Corp.

    SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    11/14/24 1:34:08 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by OrthoPediatrics Corp. (Amendment)

    SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    5/8/24 2:22:57 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by OrthoPediatrics Corp. (Amendment)

    SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    2/14/24 3:33:43 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care